ASCO 2018: Novel treatment strategies in prostate cancer therapeutics
Dr Neal Shore speaks to Prof Karim Fizazi at ASCO 2018 about the changing landscape of treatments for prostate cancer, discussing immunotherapies, PARP inhibitors and PSMA testing as future targets and treatments.
